Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which IV works best for Hard-to-Stick patients? new study aims to find out

NCT ID NCT06668766

Symptom relief Sponsor: Albany Medical College Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 26, 2026 · Updated 2 times

Summary

This study looks at two types of IV catheters for emergency department patients whose veins are hard to access. One is a standard 2-inch long IV, and the other is a longer 4-inch midline catheter inserted with a guidewire. Researchers want to see which one lasts longer and causes fewer problems. About 270 adults with difficult IV access will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

270 people

The number who actually took part.

Started

Jan 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult (age 18 and older) patients presenting to the AMC ED with difficult IV access defined as any of the following: * Two failed attempts at landmark based IV or US-guided peripheral vascular access by qualified ED staff * Self-reported history of difficult IV access and one of the following: * History of requiring 2 or more IV attempts on a previous visit (either self-reported or documented in the electronic medical record) * Previous requirement for a rescue device after failed IV access attempt. These devices are as follows: * US guided PIV * Midline catheter * Peripherally inserted central catheter * Central venous catheter * Intraosseous catheter * History of or active comorbid disease state with known difficult IV access * Prior or current implanted port device * End stage renal disease with fistula * Sickle cell disease * History of or active intravenous drug use Exclusion Criteria: * Patients under the age of 18 * Known Prisoners * Non-English-speaking patients * Patients in whom the device cannot be stabilized due to tissue or treatments in bilateral extremities or available extremity (burns, complex humeral fractures, dialysis fistulas etc.) * Patients lacking capacity to consent * Patients unable to sign written consent * Patients without identifiable target veins by ultrasonography * Known pregnant patients * Previously enrolled in this study * Previously withdrawn from this study * Presented when no study IV proceduralists are available * Patients in whom obtaining informed consent and being enrolled in the study would put them at risk for obtaining time sensitive medical care

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Difficult intravenous access are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Emergencies

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Difficult intravenous access Emergency department patient Midline catheter Peripheral intravenous catheter

Contacts and locations

Locations

  • Albany Medical Center Hospital

    Albany, New York, 12054, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.